109 results
8-K
EX-99.1
PHASQ
PhaseBio Pharmaceuticals Inc
30 May 23
Other Events
4:02pm
reconciliations for the reporting period Description of the assets sold or transferred and the terms of the sale or transfer Signature of Responsible Party … Printed Name of Responsible Party Date Address /s/ James F. McCauley 05/23/2023 James F. McCauley Richards, Layton & Finger, P.A. 920 N. King Street
8-K
EX-99.1
PHASQ
PhaseBio Pharmaceuticals Inc
27 Sep 23
Other Events
8:52am
reconciliations for the reporting period Description of the assets sold or transferred and the terms of the sale or transfer Signature of Responsible Party … Printed Name of Responsible Party Date Address /s/ James F. McCauley 09/22/2023 James F. McCauley Richards, Layton & Finger, P.A. One Rodney Square
8-K
EX-99.1
PHASQ
PhaseBio Pharmaceuticals Inc
25 Aug 23
Other Events
12:34pm
reconciliations for the reporting period Description of the assets sold or transferred and the terms of the sale or transfer Signature of Responsible Party … Printed Name of Responsible Party Date Address /s/ James F. McCauley 07/24/2023 James F. McCauley Richards, Layton & Finger, P.A. 920 N. King Street
8-K
EX-99.3
PHASQ
PhaseBio Pharmaceuticals Inc
12 Mar 24
Entry into a Material Definitive Agreement
4:34pm
of the sale or transfer
/s/ James F. McCauley
James F. McCauley
Signature of Responsible Party
Printed Name of Responsible Party
Richards, Layton & Finger … / Lawrence R. Perkins
Lawrence R. Perkins
Signature of Responsible Party
Printed Name of Responsible Party
Chief Restructuring Officer
Title
Date
UST Form 11
8-K
EX-99.2
887q367trn 04t2q
25 Aug 23
Other Events
12:34pm
8-K
EX-99.1
y5c 82pc6t7shv31
13 Jan 20
PhaseBio Announces Acquisition of Novel Oral Aldosterone Synthase Inhibitor to Develop for Treatment-Resistant Hypertension
4:07pm
10-K
EX-10.14
sxzetmwup8w7khi7b
26 Mar 19
Annual report
4:45pm
8-K
EX-99.1
l6xrkf8
10 May 23
Other Events
8:08am
8-K
EX-99.2
rxkm ejuzv
12 Mar 24
Entry into a Material Definitive Agreement
4:34pm
S-3
EX-4.2
ktu9tej5j4xjcpk9lc
27 Dec 19
Shelf registration
5:28pm
8-K
EX-99.2
qhx6oo
29 Nov 23
Other Events
4:55pm
8-K
EX-99.1
ifw0ecwlbhpop1yw
12 Mar 24
Entry into a Material Definitive Agreement
4:34pm
8-K
EX-99.1
fnm09
23 Nov 22
Departure of Directors or Certain Officers
4:08pm
8-K
EX-99.1
e1u595lejr 53
29 Nov 23
Other Events
4:55pm
8-K
y0zfog ztnorkm148sok
17 Jun 21
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab
8:13am